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Abstract 
 
Literature tracking is essential to research groups that need to keep informed and 
up-to-date of the team’s readings and findings. Specific software can address this need, 
and a variety of solutions are available on the market.  
In this dissertation, we describe how some of these solutions can be adopted by a 
pharmaceutical company’s department, and what considerations we need to formulate 
and analyze in order to satisfy user’s and company’s needs.  
  
Introduction 
 
Researchers who consult scientific documentation need to track their readings, in an 
orderly manner. This is particularly true for a pharmaceutical company’s department 
dealing with drug safety, where a few dozen specialists need to track published literature 
in relation with their products’ therapeutic area, not only on a personal level, but also to 
share information with colleagues. 
MerckSerono Global Drug Safety (GDS) department is in this respect typical, and 
we shall describe the current system for tracking literature, and highlight the advantages of 
migrating from the current listing in favour of a more appropriate solution. 
In view of this migration, we have contacted key users in order to establish their 
needs and discuss possible improvements. Major desired features emerged, such as a 
customization, ease of consultation and searching, citation facility, and especially 
definition of controlled keywords. 
At the time of writing, a project team is evaluating options for a company-wide 
solution, where GDS is part of the definition team. This dissertation benefited from 
discussions with users and other information resource specialists, but the responsibility of 
anything stated lies entirely on the author. 
Note: throughout this paper, we refer to “users” in opposition to “administrators” of a 
proposed tool. Users are staff members that can view the data, while administrators are 
the ones that can add or modify data in the tool.  
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Drug Safety and Bibliographic Data 
 
As part of the Development function of a pharmaceutical company, MerckSerono’s 
Drug Safety department ensures that drugs are monitored with respect to any safety 
issues, as well as analysing possible emerging trends and interacting with authorities to 
report relevant adverse drug reactions. The specialists are usually medical doctors, 
pharmacists or have training in other life sciences.  
Adverse events are either collected from clinical trials, or spontaneously notified from 
the post marketing setting, or are actively searched by GDS in the published literature. 
Generally speaking, the GDS scientists deal with adverse events at two levels:   
1. analysis, follow-up and reporting of individual events that occur with drugs either 
pre- or post- marketing. This analysis considers medical plausibility based on the mode of 
action and safety profile of products in the same class;  
2. analysis of clusters of events taking into account the population perspective 
(epidemiological data). 
In this setting, referring to findings by other researches is a necessity that no-one can 
overlook. In its turn, this gives rise to the necessity of collecting and tracking the consulted 
literature in a structured way. Articles that reported adverse events need to be kept for 
future reference, and are to be shown to health authorities as part of drug follow-up.  
Besides ad-hoc responses to events, at regular intervals pharmaceutical companies 
are requested by health authorities to critically review drugs already on the market, and 
deliver a periodic safety update report (PSUR). PSURs list extensively literature search 
with respect to the given drug, including those same articles that were used for detecting 
adverse events, as well as other scientific publications related to the drug and to the 
indication supporting the discussion in the PSUR.  
It is therefore useful and highly appreciated to be able to cite those articles without 
being hindered by bibliography formatting and word processor cut-and-paste, considering 
that for these reports articles cited are between 20 and 60.  
As nowadays the near-totality of scientific literature is available in electronic form, the 
department’s library consists mainly of an electronic collection of PDF files, extracted from 
scientific journals.   
In a sense, this article collection makes up for the department’s digital library, where 
the acquisition policy is dictated by the specialists’ need to follow up on the company’s 
drugs and therapeutic areas. Obviously, having such a collection is useful only if there is a 
means to access in a timely and appropriate manner this information, a task that is 
normally performed by a (library) catalogue.  
As it is often the case in library information services, data regarding a printed object 
is entered by one authority, and then generally imported by others in their own catalogues 
or database management systems.  
In this field, PubMed, a service from the US Library of Medicine (National Library of 
Medicine, NLM), gives access via a web interface to the majority of published material in 
the field. Journals, conferences and other published material are also usually exportable 
to a citation tool, or at least to a common index by the NLM. Similarly, all journal 
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publishers give the possibility to export article citations to a file, very often giving the 
choice of a few formats or bibliographic management tools.  
Having a common base for bibliographic references not only makes it easier to add 
new entries to a catalogue, it also limits errors (e.g., typing, spelling, omissions, etc.) that 
would be frequent in such subject area. In addition, since PubMed assigns an 
identification number to each article, this can be exploited for rapidity of access and cross 
referencing. 
What is in place now? 
 
Currently, a listing in tabular form exists, that has been in place since 2002. This 
solution is a plain flat listing, which fulfills the need of identifying which PDF file 
corresponds to which bibliographical entry. A department-specific article coding was put in 
place, which classifies articles according to the drug referred to or possible event, and if it 
was used as a reference in a report. 
This listing does not, however, allow for data to be automatically imported via 
PubMed or any other provider, nor exported and cited as bibliographic references in one’s 
report. 
When a specialist requests an article, the documentalist enters the meta-data 
supplied by the requester, proceeds to obtain the article and once the article is obtained, a 
link to the local PDF file is also added. 
1
 
 
 
Figure 1: Current article search and distribution flow 
 
To sum up, the flow in place is the following: 
                                                 
1
 The cases of articles not being obtained are extremely rare, and we do not therefore analyze this possibility 
any further. 
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• the documentalist enters bibliographical data (title, author, journal, issue, 
etc.) and the link to the PDF file; 
• the specialist assigns the code, hands it on to the documentalist for the 
classification of the corresponding article; 
• any specialist can access this listing, search through it (one term at a time 
only), view the references contained in it and any PDF file it links to. 
The classification in place assigns terms according to a department-specific 
nomenclature. Below is a snapshot of these fields and their significance: 
 
Class 
 
which product, 
substance, or 
class of illness 
is being 
reported here 
(e.g., “23” for 
Interferon-beta, 
Rebif) 
Sub-Class 
 
MedDRA
2
 
classification of 
adverse events 
(a 2-digit 
defining a 
system-organ 
class, e.g., “21” 
for reproductive 
health)  
Source 
 
if the requester 
wants to keep 
information 
about how the 
article was 
obtained, (e.g., 
via local 
representative, 
etc.)  
Report 
 
if the article is 
linked to a 
PSUR or to a 
DER 
Key Words 
 
any other 
keyword not 
present in the 
title or implicit in 
class / sub-
class 
(non-controlled 
terms) 
 
Table 1 Article listing's current classification 
 
The class and sub-class coding have a double duty. On the one hand they are 
assigned by the specialists, and can be used by them to retrieve or identify one or more 
articles. On the other, when the system was put into place in 2002, only about half of the 
articles were available as PDF files; there was therefore a need to file paper copies, and 
this classification was suitable for the task.  
Since its introduction, this listing initially served the department’s needs well. More 
recently, though, considering the increase of articles, the listing approach shows its limits 
and shortcomings. Users have trouble sieving through a few thousands entries, the 
software does not enable multiple term searches (e.g., author=smith and title=cardiac and 
year=2004), which makes searching lengthy and tiresome.  
Moreover, citation features are critically needed for writing (sometimes) lengthy 
bibliographies, and the availability of citation software makes the current approach 
redundant.  
Good search functionalities are also a major request, since users are very literate in 
database search and can manage sometimes complex queries. 
In January 2007, Serono merged with Merck Ethicals Division, which brought two 
separate Drug Safety departments to integrate and harmonize their processes.  
This subsequent larger need for documentation tracking further motivated the 
necessity for a change. Merck’s Safety in Darmstadt  was also in search of an article 
tracking, or document repository, but had not constructed a listing of previous articles 
                                                 
2
 Please refer to the acronyms listing at the end of the paper. 
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within the department. 
Serono’s listing currently holds ca. 4300 articles, starting from 2002. In the period 
January to June 2007, circa 400 entries have been added.  
The status quo is not satisfactory for the reasons listed above: bad search facilities, 
lengthy data entry, error insertion, possible work duplication, non-existent citation 
facilities.. 
 
 
Changing for the better 
 
How are we going to go about it? What is our wish list? What do we need to 
foreseeably include in this tool? What do the users want? 
First of all, we enquired about the original thought behind the solution put in place in 
2002, we gathered input from a focus group, surveyed the other in-house software 
solutions and solicited advice from in-house information specialists.  
We came to consider migrating the listing to a bibliography management tool, and 
during our discussions with other departments we came to learn of a more company-wide 
solution being put into place, which we describe in Section Options investigated.  
A company-wide common repository would allow for a number of specialists in 
different departments to access the same articles without creating duplication of effort, 
data, and files. In addition, given the interaction that some departments have, this would 
improve flow of information. 
 
Focus Group Survey 
 
The specialists who have been using the listing for at least 3 years find the status 
quo is useful, but would certainly welcome integrated solutions with citation importation for 
reports and better search functionalities.  
As reported in Table 1, specialists rely on the classification entries, and when these 
are left empty they rely on author’s name or title of the article. As mentioned,   
• the coding is important only if paper-only copy exists of article (in which case the 
coding is the cataloguing reference for the article, being kept in a hanging file 
folder) 
• the coding is important for DER tracking 
• the coding is important for PSUR or any other report tracking 
The survey with the focus group brought the conclusion that a literature database 
was indeed much needed.  
As the current system contains a number of fields dedicated to the department’s 
classification, a similar flexibility would be sought in the new tool. These specific fields are 
especially important to link adverse cases to articles, and to re-access previously used 
literature for further use (e.g. for PSUR).  
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It remains to be defined what type of tool would be selected for the task, and the 
number of articles that would be migrated to the new tool. 
 
Users’ information literacy 
The sought tool is going to be used by users that have a fairly good level of 
information literacy, who know when to rely on standard searches and when to resort to 
advanced search, and navigate between standard search terms (author, title, journal) and 
company-specific terms. 
Possibly, users will be accessing the database via a querying system on a web 
interface, while the database is to be fed by information specialists or external vendors. 
 
Options investigated 
 
Essentially, four types of tools can be taken into consideration.  
1. custom-made database  
the choice is vast, it involves a lot of work and implementation,  
2. off-the-shelf bibliographic database or bibliography management tool 
(BMT)  
here the choice is less vast, and may include proprietary and open-source tools 
3. document management systems (DMS)  
proprietary and open source tools exist; a big drawback is in the citation 
management and import of entries. 
4. product literature database (PLD) 
internal or fully or semi-outsourced solution, whereby a vendor manages the 
database, both feeding it with new articles and sending alerts to the specialist; it is 
a specialized database that pre-digests newly published material regarding one 
specific drug or substance.   
Within the company, a project is underway to select a tool, and GDS is collaborating 
with other departments with similar literature needs on specifications and choices. 
 It is necessary to keep in mind that an off-the-shelf bibliographical management tool 
is often conceived for a single user, or for a limited number of users, or for a limited 
number of articles. The needs of dozens of users (if not in the hundreds), who are very 
large consumers of scientific literature, might not be met by a majority of these tools
3
.  
In schematic form, we have three objects: the PDF file, the PubMed (or any other 
publicly available) meta-data describing it, and the department-specific information. The 
clear importance and advantage of one system over another is in the flexibility it might 
offer to include the department-specific data, since this is a feature that really makes the 
tool apt for the job, and, more importantly, one of the requests from the focus group.  
                                                 
3
 As an example, some citation tools have a limit to 50,000 items, which is already the current holding of the 
Medical Information department. For a company-wide solution, this figure would be attained in less than one 
year.  
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Department-specific data is a controlled vocabulary set or code (the drug class, the 
MedDRA system organ class), but also semi-controlled data (for instance, the type of 
report the reference was used for, or some descriptive text regarding the article). 
A custom-made database solution would require some heavy work from 
programmers within the company or from consultants. It would certainly allow for high 
customization, but would also bring debugging and system maintenance with it, both 
rather time- and energy-consuming tasks. Even if this option is not discarded right away, 
the downsides involved in setting up such a piece of software, considering the availability 
of commercially viable options, do not make this solution a highly likely candidate. 
 Likewise, a document management system, originally intended for sharing 
documents across different users and sites, is more geared towards tracking revisions of 
documents and version control. It can be used as a simple repository of articles, and 
would allow a lot of flexibility for descriptive fields. Two major drawbacks of a DMS are the 
lack of the citation facility, and the unlikely importing of bibliographical data from PubMed 
or any other provider, again central to user’s requests. 
By elimination, two final classes of products are therefore in line: a bibliography 
management tool and a product literature database. 
 
What is a bibliography management tool? 
A BMT is a piece of software that allows writers to keep track of their literature 
search and work, making it easier to include specific citations in a word processor, without 
dealing too much with formatting; moreover, a BMT often acts as a database for all 
articles used, allowing for searching and retrieving not only the meta-data but usually also 
a locally-accessible PDF file of the article in question. From this point of view, a BMT acts 
as a document repository.
4
 
One of BMTs main features is the possibility to import citations (e.g., from an on-line 
catalogue or other databases), which makes feeding the tool itself less cumbersome and 
avoids data-entry errors. Also noteworthy the possibility to include personal notes, 
annotations on the record itself, that is later visible as part of the article’s entry. 
Specific questions arise with respect of this department’s needs. These include: 
• the need for customizable fields (see above for MedDRA classes) 
• accessibility on a number of sites (Geneva, Darmstadt, and possibly other 
corporate locations).  
For our specific purposes, it would be wise to customize the user’s annotation facility 
within specific boundaries.  
Indeed, in most off-the-shelf applications this field is a free-text area, where usually 
the user jots down his own remarks on a document, like one would do in pencil on the 
margin of a paper document. It is a useful feature, especially for the solo researcher who 
enters data in the tool, manages and uses it by himself. However, as soon as the tool is to 
be used by a number of different people (even a potentially large number, say one 
hundred or so), the need for a more structured and controlled set of data for this field 
                                                 
4
 Of the number of tools available, the bibliography lists some reviews (open access articles) that highlight 
each tool’s functionalities and specificity. Since we did not however carry out an on-site test ourselves, we 
refer the reader to these articles or to the product’s web site for information.  
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becomes evident. 
If we want to allow free-text annotation, we should investigate for more than one 
annotation field, so that controlled data can be entered in one (aptly named something like 
“MedDRA information”, for instance, or “GDS classification”), and more informal 
descriptors (e.g., “cited by Brown and Smith, 2005”) should be entered in a separate field. 
 
What is a product literature database (PLD)? 
These tools have entered the market lately, and go loosely under the name of 
“product literature database”. They are specifically geared to the pharmaceutical 
companies’ needs to constitute a database listing all scientific literature published in 
relation to a specific product or substance. An outside vendor is generally entrusted to 
scan regularly for newly published material regarding a specific drug, classify the findings 
in a pre-established manner (e.g., by drug interaction, by dosage, by geographical 
distribution, and so on), and supply both the article itself and the full classification meta-
data. 
PLDs being rather new products, they are not very well known, few vendors are on 
the market for the time being, but they can offer the flexibility that usually comes with 
novelty.  
The advantage of this type of solution is that it can provide full-text search in all the 
articles it has collected, so that highly narrowed queries can be formulated.  
A second advantage is the availability in the database of articles published by any 
journal, regardless of its publisher or its open access availability
5
. 
Starting from the assumption that a specialist is interested primarily in one drug and 
its interactions, a PLD groups up articles by substance or drug name (the “product”). In 
this way, searching for example for “cardiovascular diseases” will scope only on this class 
of diseases and the chosen drug.  
This operation provides not only the economy of typing a search term. In scientific 
articles, a drug name can be present in the title, in the abstract or in the full text; under its 
marked brand name or as a substance; sometimes it is assimilated to a class of drugs 
(e.g., corticoids). PLD vendors carry out a mapping of a number of terms, strongly in 
relation with one specific drug, and gather under one single term articles in relation with 
the company’s product.  
PLDs can also implement full-text search on articles available in the database. This 
can be viewed as both a strength and a complication. Full text search can retrieve 
otherwise unfound sources, since certain terms would not show up as keywords or in the 
title/abstract part of the article. On the other hand, this strategy is going to lead to the 
retrieval of articles that are potentially of little relevance to the original query (creating 
“noise”).  
Therefore, it might be advisable to include full-text search as an optional 
functionality, for instance as a section button in the advance search interface.  
 
                                                 
5
 Copyright issues are not the focus of this work, and we need content ourselves with the assurance that the 
vendors are to acquire copyright permission from holders. 
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Considerations common to all options 
 
Whatever the new tool will be, a few considerations should be common. These are 
intended to make stakeholders more at ease with the tool at first encounter, and thus 
favouring use of the tool and assuring its actual usefulness. 
 
Nobody disputes the advantages of having a web interface, since the browser’s 
functionalities are acquired for free, and users are well-accustomed with this tool already.  
In addition, since databases work typically on a client/server architecture and this also is a 
typical web interface, putting them together comes rather naturally.  
 
A second consideration is the possibility to export the database to a different 
formatting, in order to secure the repository from software obsolescence, or any other 
reason that might make accessing it no longer possible. This links with the web-interface 
aspect, which should facilitate exporting. 
 
Access to the database on various corporate sites, prompt update of the database’s 
indexes, especially when an outside vendor is involved, are also worthwhile 
considerations. 
 
For the search functionality, a “basic” Boolean search should be offered, together 
with a more advanced one. In this latter case, nested searches might be useful (e.g., 
entering as search criteria ((lung AND infection) OR pneumonia). This search type would 
be especially useful if full-text access on the PDF files is made possible, but not so vital if 
all search criteria can only rely on the article’s meta-data. 
 
Apart from these, we take for granted that common search functionalities by title, 
author’s name, date, journal, etc. will be available.  
 
As mentioned earlier, the ease with which references can be cited is crucial. 
Exporting bibliographical references in a pre-defined format with a few mouse clicks is a 
task at which the tool should excel, enabling users to include references in a word 
processor in different referencing formatting styles.   
 
It is however unclear if the tool will benefit from compliance with the Z39.50 protocol 
for cataloguing. This protocol intends to make possible the communication between 
databases that are linked via an internet connection. It is much more geared to integrated 
library systems than to bibliographic or citation tools. However, since part of the tool is to 
deal with importing citations and this protocol deals specifically with data exchange, 
conformity with this protocol might be a precaution to keep in mind.  
 
Looking back to Serono’s original listing, and regardless of the tool that will be 
selected, the following fields are to be considered: 
 
standard features (title, authors, source, date) 
medical literature specific identifiers: PubMed unique identifier (PMUI), other medical 
databases identification number; note however that not all articles have a PubMed id, e.g., 
not all non-English language articles are listed; if implemented, we have to allow for this 
field to remain empty. 
 12 
For the articles that do have a PMUI, it is a convenience to be able to re-enter the 
number and, for instance, retrieve from that database related articles, or articles that cite 
the original paper, etc. One could arrive to this result in other ways (e.g., re-entering 
author and title), but accessing the information with one single code is a definite time 
saver.  
 MedDRA coding: its usefulness was crucial for paper-only articles, since it provided 
classification for storage; nowadays, since all articles are on-line PDF files, this aspect is 
not crucial for storage, but is still relevant for the specialist’s searches. 
electronic publishing identifiers: DOI (digital object identifier) codes are unique codes 
assigned by the publisher (or at least at the publisher’s request). Because more and more 
articles are being extracted from the full publication’s issue, the need arose to identify 
documents with a permanent code. In our case, it might be redundant to list both PMUI 
and DOI, and this double entry might just be a safety net for classification purposes. Note 
however that this field is absent from older articles (pre-1999) and possibly from articles 
received via interlibrary loan. 
 
. 
 
Figure 2: database citation  structure 
 
 
Access to this database would be open to all staff of the GDS department, identified 
via IP. Contrary to other pharmacovigilance data, where confidential information regarding 
patients can be present, data contained in published scientific articles is, by definition, 
public knowledge, and does not therefore require special protection.  
Drug safety specialists are the primary consulting users of this database, but in 
practice any GDS staff member should be granted access to the data: for example, the 
data-entry clerk could need a reference for the authorities’ report, a compliance specialist 
might need an article, as well as other non-regular users’ requirements. This consideration 
is not a secondary one, in that it bears consequences on the user-friendliness of the 
design and interface. 
 
The tool needs to be accessible to users in at least 3 “main” sites, i.e., Geneva (CH), 
Darmstadt (D) and Rockland (USA). However, ideally, it would be preferable that all users 
 
   database 
PubMed or 
other imports  manual 
entries 
search 
facilities  
Report 
……. 
References 
citation  
filter(s) 
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worldwide who have a need to access this database could consult it at their desktop via 
the company’s network. At the time of writing the feasibility of this aspect has not yet been 
ascertained, since a number of considerations beyond the scope of this dissertation need 
to be taken into account.   
 
 
Conclusions 
 
There is nothing very novel about setting up a database of articles, importing 
citations from a database, including references in a report, tracking articles previously 
read, and building a library of PDF files. 
What we have outlined here is the complexity of choosing a tool that would allow 
different people in different sites to access such a database, and access not only the 
actual meta-data (i.e., the bibliographic reference), but also the PDF file it refers to, 
provide search criteria for in-house specific data (e.g., MedDRA coding, PSUR reference 
and the like), as well as classical fields (e.g., author, title, etc.). A company-specific, 
customized tool is to be selected and different types of users have been consulted 
regarding their requirements. 
Although this report relates very much a work-in-progress state of affairs, it highlights 
the need for consulting the final users, survey the available options, analyzing advantages 
and disadvantages of each envisaged solution.  
There is a conspicuous absence of reference to costs that any of the solutions would 
engender. One reason is that since the customization is such a significant part a PDL, its 
cost can vary depending on the final requirements. At this point of the project’s life, we 
cannot therefore give any indications or use this aspect as a comparison vis-à-vis a BMT.  
Finally, looking to the future and imagining migrating at least part if not the totality of 
the data, means that exporting the base (possibly via an independent computing 
language/platform) needs to be an investigated aspect or requirement. 
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